-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
MoonLake Immunotherapeutics quarterly/annual Operating Lease, Payments history and growth rate from 2022 to Q1 2025.
- MoonLake Immunotherapeutics Operating Lease, Payments for the quarter ending March 31, 2025 was $368K, a 1.1% increase year-over-year.
- MoonLake Immunotherapeutics annual Operating Lease, Payments for 2024 was $1.47M, a 249% increase from 2023.
- MoonLake Immunotherapeutics annual Operating Lease, Payments for 2023 was $422K, a 180% increase from 2022.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)